Cero Therapeutics Holdings CERO
OTC CERO
$0.00 -0.01 (-100.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings, Inc. (CERO) Return on Capital Employed [ROCE] (2023)

Updated

Cero Therapeutics Holdings (CERO) recorded Return on Capital Employed [ROCE] of -228.14% in Q4 2023, down 109.88 percentage points from the prior quarter.

Analysis

Cero Therapeutics Holdings, Inc. (CERO) Return on Capital Employed [ROCE] (2023) Analysis & Trends

For FY2023, Cero Therapeutics Holdings reported Return on Capital Employed [ROCE] of -37.92%, down 34.31 percentage points from FY2022.

  • Across earlier years, Return on Capital Employed [ROCE] came in at -3.61% in FY2022.
  • Per Business Quant, the preceding three quarters came in at -118.26% (Q3 2023), -70.76% (Q2 2023) and -19.67% (Q1 2023).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -228.14%
Sep 30, 2023 -118.26%
Jun 30, 2023 -70.76%
Mar 31, 2023 -19.67%
API Access

Cero Therapeutics Holdings, Inc. Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CERO&period=max&api_key=YOUR_API_KEY